HOME >> BIOLOGY >> NEWS
Celebrex may be safe for preterm labor, preliminary study finds

St. Louis, Sept. 23, 2002 -- The drug celecoxib may be a safer alternative for treating preterm labor than traditional therapies, according to a preliminary study led by Washington University School of Medicine in St. Louis. The study is published at the end of the month in the September issue of the American Journal of Obstetrics and Gynecology, and appears on the journal's website today.

One of the established treatments to prevent preterm delivery is indomethacin, a drug used to slow uterine contractions and delay delivery. But indomethacin is associated with severe side effects. Recent research suggests that celecoxib, also known as celebrex, may be a safer alternative. This study is the first clinical trial testing celecoxib in pregnant women.

"Celecoxib appears to be safer, particularly for the fetus," says Yoel Sadovsky, M.D., director of the Division of Genetics, Maternal-Fetal Medicine and Ultrasound at the School of Medicine. "These preliminary results also suggest that celecoxib is just as effective, and we are currently planning a larger trial to further examine its effectiveness."

The study was a combined effort between Washington University and Northwestern University. Sadovsky, also associate professor of obstetrics and gynecology and of cell biology and physiology, led the study. The first authors are Catherine S. Stika, M.D., at Northwestern University and Gilad A. Gross, M.D., assistant professor of obstetrics and gynecology at Washington University.

According to the American College of Obstetrics and Gynecology, about 1 in every 10 births in the United States occurs within the first 37 weeks of pregnancy and therefore is considered "preterm." Preterm labor is responsible for about 75 percent of newborn deaths not related to birth defects, and preterm infants often experience life-long complications.

Indomethacin, one of the standard drugs used to treat preterm labor, prevents the production of a type of p
'"/>

Contact: Gila Z. Reckess
reckessg@msnotes.wustl.edu
314-286-0109
Washington University School of Medicine
23-Sep-2002


Page: 1 2

Related biology news :

1. Case researchers substantiate bacterial link to preterm birth through mice studies
2. New ACOG guidelines on progesterone to prevent preterm birth praised by March of Dimes
3. Preeclampsia linked with higher risk of preterm delivery
4. Preeclampsia linked with higher risk of preterm delivery and later-life vascular disease
5. Predicting preterm birth still nearly impossible, study in New England Journal finds
6. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
7. Two-drug approach might shorten painful labor, reduce Caesarean sections
8. Society report encourages preliminary sex analysis of clinical trial data
9. Contract bridge enhances the immune system, according to a preliminary study by researchers at UC Berkeley
10. Novel anti-cancer agent shows minimal side effects with preliminary evidence of tumor shrinkage
11. Student science contest participation influences study, career choices, alumni say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/13/2018)... ... ... Illumina, Kaiser Permanente, ResMed and Aetna were just a few of the ... events company has hosted an impressive guest list of Fortune 500 businesses, namely due ... who visits receives a completely customized experience, right down to the menu and the ...
(Date:12/13/2018)... , ... December 13, 2018 , ... ... released a must-see documentary entitled “What Researchers Need to Know about Antibody ... in Life Science Research series. The goal of this film is to educate ...
(Date:12/10/2018)... ... December 10, 2018 , ... Today, RoosterBio ... their shared goal of accelerating the development of the Regenerative Medicine field. ... TRT’s core technology around human umbilical cord perivascular cells (HUCPVCs). Together, it ...
Breaking Biology News(10 mins):
(Date:12/13/2018)... ... December 12, 2018 , ... Helping conclude Healthy Aging Month this past September, ... aid within its Vision and Hearing campaign that sets out to shed light on ... despite continued efforts to destigmatize hearing aids over the years, 9 out of 10 ...
(Date:12/10/2018)... SAN DIEGO (PRWEB) , ... ... ... Ltd., a fully integrated Contract Development and Manufacturing Organization (CDMO) with sites ... characterization, conjugation optimization, cGMP manufacturing, and aseptic fill finish solutions for monoclonal ...
(Date:12/5/2018)... (PRWEB) , ... December 05, 2018 , ... The incredible ... paid tribute to in the European Parliament by Carlos Moedas, the European Commissioner for ... EU Research and Innovation in Our Daily Lives, Commissioner Moedas spoke at length of ...
(Date:12/5/2018)... CHARLOTTESVILLE, Va. and LONDON (PRWEB) , ... ... ... Atlantic Research Group (ARG), an established North American full-service contract research organization ... CRO. Effective immediately, the transaction significantly strengthens ARG’s reach and experience in ...
Breaking Biology Technology:
Cached News: